In the case of semaglutide 2.4 mg, it promotes a reduction in ad-libitum food consumption via reduced appetite, less preference for energy dense fatty foods, and reduced cravings. dom-pubs.onlinelibrary.wiley.com/doi/10.1111/do…
Teacher, Clinical Supervisor, [AIdvisor]
Retired Clinical Associate Professor, Psychiatry, University of Florida
Affiliation is for identification only. All content and opinions are my own.
View more posts
Gator Psychiatry 